Amphastar Pharmaceuticals Inc (AMPH) Stock Price Today
Aura AI Summary
Key Stats
- $838.65MMarket Cap
- -Volume
- HealthSector
- $30.8152W High
- $16.8752W Low
- -Typical Hold Time
- $1.23BEnterprise Value
- -Div Yield
- -Trading Activity
Track Amphastar Pharmaceuticals Inc (AMPH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $16.87 and a high of $30.81, highlighting its annual price range. Buy and sell Amphastar Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Most Recent News
RiverNorth Opportunities Fund offers 13.48% yield with tactical allocations but carries risks from SPAC exposure.
The RiverNorth Opportunities Fund (RIV) provides a high yield of 13.48% by investing tactically in closed-end funds, SPACs, BDCs, and ETFs. Its largest allocation to special purpose acquisition companies (SPACs) adds diversification but also increase...

Renewed U.S.-Iran tensions push oil prices up, impacting key economic sectors and confirming AI investment confidence.
Renewed hostilities between the U.S. and Iran, including attacks on commercial vessels in the Strait of Hormuz and reinstated U.S. sanctions on Iran, caused crude oil prices to rise sharply. This increase pressured economically sensitive sectors such...

Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
